Abstract
Pre-symptomatic genetic and genomic testing can identify individuals at increased disease risk before symptoms develop, but implementation depends on more than analytical validity or test availability. This review updates the evidence on barriers and facilitators to implementation after the search period of Shen et al. [2].
PubMed was searched on 3 August 2026 using three separately constructed search sets covering genetic/genomic testing, presymptomatic or asymptomatic screening, and implementation; the final PubMed History search combined these as #1 AND #2 AND #3. Results were limited to English-language publications from 2020–2026, followed by a publication-boundary audit excluding records published on or before 22 May 2020. Study selection, critical appraisal, extraction, and synthesis were conducted by a single reviewer. Design-appropriate Joanna Briggs Institute (JBI) tools were used [3]. Findings were coded as barriers or facilitators, assigned to implementation levels, and mapped to the 58 themes reported by Shen et al. or to new themes.
A total of 824 PubMed records were identified before the recorded filtering step and 347 remained for title/abstract screening. Of these, 256 were excluded and 91 reports were sought for full-text retrieval. Eleven reports were not retrieved; 80 full texts were assessed and 17 were excluded, leaving 63 studies in the narrative synthesis. The extraction contained 424 barrier/facilitator findings. Thirty-four of the 58 earlier themes were confirmed and 24 were not addressed. Seventeen additional implementation themes were identified. Carepathway design and follow-up infrastructure, health equity and representativeness, workforce capacity and training, provider inadequate knowledge, family dynamics in cascade testing, logistics of sample collection and access, organisational readiness, and perceived cost were among the most widely represented themes.
Within this PubMed-based update, the post-2020 evidence places substantially greater emphasis on organisational and health-system implementation than the earlier review. Pre-symptomatic testing depends on complete care pathways for recruitment, informed decision-making, sample collection, result communication, counselling, referral, surveillance, prevention, and treatment. Findings should be interpreted in light of the PubMed-only search, English-language restriction, single-reviewer workflow, 11 unretrieved reports, lack of prospective protocol registration, and heterogeneity of the evidence.